Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Prevention of Postoperative Hernias in Emergency Surgery

NCT06815822 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2025-06-01
Last updated
2025-06-15

Condition(s) studied

Incarcerated HerniaAppendicitis AcuteCholecystitis, AcuteIleusPerforated Gastro-duodenal UlcersPerforated Bowel

Study summary

The aim of this observational study is to understand the risk factors and incidence of postoperative hernias among patients undergoing emergency surgery. The main question it aims to answer is:

What is the incidence of postoperative hernias in this group of patients?

A brief telephone interview will be conducted with participants who will be included in this study one year after the surgery. If the presence of a postoperative hernia is suspected, the patient will be invited to a follow-up visit to the surgical clinic, where the diagnosis will be confirmed by imaging tests.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion criteria: * Patient age \> 18 years. * Emergency or urgent surgery. * Specific surgical indications (acute appendicitis, acute cholecystitis, incarcerated hernia, gastrointestinal perforation, and obstruction). Exclusion criteria: * Lack of patient consent. * Open abdomen technique applied.

Primary outcome measure(s)

  • Incisional hernia — From the moment of inclusion until one year from the date of surgery.
    Occurrence of postoperative abdominal hernia in the incision line.
  • Port-site hernia — From the moment of inclusion until one year from the date of surgery.
    Occurrence of port-site hernia after laparoscopy.
  • Parastomal hernia — From the moment of inclusion until one year from the date of surgery.
    Occurrence of a parastomal hernia after open/laparoscopic stoma formation

Trial sites (1)

FacilityCityRegionStatus
Department of General Surgery, St Alexander Hospital Kielce Poland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06815822 on ClinicalTrials.gov ↗ ← All trials in Poland